Comparison of Clinical Efficacy of a Dentifrice Containing 5% Fluoro Calcium Phosphosilicate to a Dentifrice Containing Calcium Sodium Phosphosilicate on Dentinal Hypersensitivity

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

131 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-12-20

Study Completion Date

2018-02-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim of this study was to assess and compare the efficacy of a dentifrice containing 5% fluoro calcium phosphosilicate and dentifrice containing calcium sodium phosphosilicate on Dentinal Hypersensitivity (DH) compared to a placebo over a period of 6 weeks.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of Efficacy of 5% Fluorocalcium Phosphosilicate Dentifrice and Potassium Nitrate Dentifrice on Dentinal Hypersensitivity

NCT03738514

Dentinal Hypersensitivity

COMPLETED PHASE2

Clinical Study to Evaluate the Efficacy of Two Dentifrices for Dentine Hypersensitivity

NCT02371616

Dentine Sensitivity

COMPLETED NA

The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity

NCT02612064

Dentin Sensitivity

COMPLETED NA

Study Investigating Efficacy of an Occluding Dentifrice for Dentine Hypersensitivity

NCT02705716

Dentin Sensitivity

COMPLETED NA

A Clinical Method Development Study to Characterise The Efficacy of a Dentifrice For The Relief Of Dentin Hypersensitivity

NCT03361774

Dentin Sensitivity

WITHDRAWN PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A total of 131 subjects were divided into 3 groups randomly. Group I was given the dentifrice containing 5% fluoro calcium phosphosilicate ,Group II was given the dentifrice containing calcium sodium phosphosilicate and group III was given placebo. Sensitivity scores (VAS score) were recorded at baseline, 2 weeks, 6 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dentinal Hypersensitivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I

dentifrice containing 5% fluorocalcium phospho silicate prescribed and VAS score assessed at Baseline, 2 weeks, 6 weeks.

Group Type ACTIVE_COMPARATOR

5% fluorocalcium phosphosilicate dentifrice

Intervention Type OTHER

dentifrice containing 5% fluorocalcium phosphosilicate and VAS score assessed at Baseline, 2 weeks, 6 weeks.

Group II

dentifrice containing Calcium sodium phosphosilicate prescribed and VAS score assessed at Baseline, 2weeks, 6 weeks .

Group Type SHAM_COMPARATOR

Calcium sodium phosphosilicate

Intervention Type OTHER

Calcium sodium phosphosilicatand VAS score assessed at Baseline, 2weeks, 6 weeks.

Group III

dentifrice without the active ingredient prescribed and VAS score assessed at Baseline, 2weeks, 6 weeks.

Group Type PLACEBO_COMPARATOR

Placebo dentrifice

Intervention Type OTHER

placebo dentifrice and VAS score assessed at Baseline, 2weeks, 6 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

5% fluorocalcium phosphosilicate dentifrice

dentifrice containing 5% fluorocalcium phosphosilicate and VAS score assessed at Baseline, 2 weeks, 6 weeks.

Intervention Type OTHER

Calcium sodium phosphosilicate

Calcium sodium phosphosilicatand VAS score assessed at Baseline, 2weeks, 6 weeks.

Intervention Type OTHER

Placebo dentrifice

placebo dentifrice and VAS score assessed at Baseline, 2weeks, 6 weeks.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The volunteers selected at baseline were in good general health and should have at least 20 natural permanent teeth and history of hypersensitivity to hot, cold, sour stimuli on at least two teeth with a VAS score of ≥4.

Exclusion Criteria

* Patients with active cervical caries or deep abrasion requiring cervical filling, chipped teeth or fractured cusps, tender tooth in same quadrant as the hypersensitive teeth, Subjects using any type of desensitizing paste or desensitizing therapy for last 6 months, Pregnant/ lactating women or subjects with history of chronic use of anti-inflammatory and analgesic medications were excluded.

Minimum Eligible Age

25 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes